InvestorsHub Logo
Followers 30
Posts 4193
Boards Moderated 0
Alias Born 07/25/2007

Re: DewDiligence post# 2119

Friday, 01/07/2022 12:45:18 PM

Friday, January 07, 2022 12:45:18 PM

Post# of 3059

• EDP-235 phase-1 starting Feb 2022. (EDP-235 is a SARS-CoV-2 protease inhibitor.)



Glad to see that EDP-235 will be finally entering the clinic in about a month. I will feel a lot better when ENTA also chooses one of more other candidates for Hep-B and enters human trials with them. ENTA's goal of functional cure requires one or more to combine with EDP-514.

I looked at their Covid-19 protease inhibitor from PRDS and EDP-235 looks more potent but they are ahead in trials. Your idea of hedging with it sounds reasonable.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News